🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/04/2010 | 6,48 | 6,63 | 6,44 | 6,44 | -1,15% | 2,89% | 60.300 |
| 09/04/2010 | 6,59 | 6,59 | 6,48 | 6,51 | -1,70% | 1,70% | 52.739 |
| 08/04/2010 | 6,51 | 6,63 | 6,44 | 6,63 | +1,14% | 2,87% | 42.373 |
| 07/04/2010 | 6,44 | 6,66 | 6,44 | 6,55 | +1,16% | 3,49% | 80.631 |
| 06/04/2010 | 6,48 | 6,51 | 6,44 | 6,48 | -0,57% | 1,16% | 104.382 |
| 05/04/2010 | 6,44 | 6,51 | 6,40 | 6,51 | +1,75% | 1,74% | 46.434 |
| 01/04/2010 | 6,59 | 6,70 | 6,36 | 6,40 | -1,72% | 5,11% | 89.608 |
| 31/03/2010 | 6,44 | 6,59 | 6,36 | 6,51 | +0,58% | 3,49% | 116.378 |
| 30/03/2010 | 6,48 | 6,74 | 6,40 | 6,48 | +0,00% | 5,20% | 71.521 |
| 29/03/2010 | 6,70 | 6,81 | 6,48 | 6,48 | -2,81% | 5,03% | 66.685 |
| 26/03/2010 | 6,59 | 6,70 | 6,59 | 6,66 | +1,14% | 1,70% | 36.415 |
| 25/03/2010 | 6,81 | 6,85 | 6,59 | 6,59 | -2,22% | 3,85% | 74.085 |
| 24/03/2010 | 6,85 | 7,04 | 6,74 | 6,74 | -1,64% | 4,37% | 84.345 |
| 23/03/2010 | 6,85 | 6,96 | 6,77 | 6,85 | +0,55% | 2,73% | 131.686 |
| 22/03/2010 | 6,63 | 6,92 | 6,59 | 6,81 | +2,25% | 5,09% | 58.910 |
| 19/03/2010 | 6,77 | 6,92 | 6,55 | 6,66 | -1,11% | 5,52% | 142.587 |
| 18/03/2010 | 6,92 | 6,96 | 6,74 | 6,74 | -3,22% | 3,24% | 60.113 |
| 17/03/2010 | 7,15 | 7,19 | 6,96 | 6,96 | -2,62% | 3,14% | 110.714 |
| 16/03/2010 | 7,07 | 7,19 | 6,96 | 7,15 | +1,06% | 3,17% | 264.442 |
| 15/03/2010 | 6,70 | 7,26 | 6,55 | 7,07 | +8,62% | 10,62% | 568.451 |
| 12/03/2010 | 6,29 | 6,59 | 6,25 | 6,51 | +3,57% | 5,36% | 273.792 |
| 11/03/2010 | 6,33 | 6,44 | 6,21 | 6,29 | -1,18% | 3,55% | 103.901 |
| 10/03/2010 | 6,40 | 6,66 | 6,33 | 6,36 | +0,00% | 5,26% | 105.932 |
| 09/03/2010 | 6,36 | 6,55 | 6,33 | 6,36 | +0,00% | 3,53% | 66.444 |
| 08/03/2010 | 6,74 | 6,74 | 6,33 | 6,36 | -5,56% | 6,11% | 225.275 |
| 05/03/2010 | 6,63 | 6,74 | 6,59 | 6,74 | +2,27% | 2,26% | 223.244 |
| 04/03/2010 | 6,66 | 6,74 | 6,51 | 6,59 | +0,00% | 3,37% | 162.384 |
| 03/03/2010 | 6,74 | 6,74 | 6,48 | 6,59 | -1,68% | 3,89% | 96.233 |
| 02/03/2010 | 6,44 | 6,74 | 6,33 | 6,70 | +0,56% | 6,40% | 159.632 |
| 01/03/2010 | 6,66 | 6,70 | 6,55 | 6,66 | +1,14% | 2,25% | 193.723 |